Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Toxins (Basel) ; 8(12)2016 12 09.
Article in English | MEDLINE | ID: mdl-27941686

ABSTRACT

Venom gland transcriptomic and proteomic analyses have improved our knowledge on the diversity of the heterogeneous components present in scorpion venoms. However, most of these studies have focused on species from the family Buthidae. To gain insights into the molecular diversity of the venom components of scorpions belonging to the family Superstitioniidae, one of the neglected scorpion families, we performed a transcriptomic and proteomic analyses for the species Superstitionia donensis. The total mRNA extracted from the venom glands of two specimens was subjected to massive sequencing by the Illumina protocol, and a total of 219,073 transcripts were generated. We annotated 135 transcripts putatively coding for peptides with identity to known venom components available from different protein databases. Fresh venom collected by electrostimulation was analyzed by LC-MS/MS allowing the identification of 26 distinct components with sequences matching counterparts from the transcriptomic analysis. In addition, the phylogenetic affinities of the found putative calcins, scorpines, La1-like peptides and potassium channel κ toxins were analyzed. The first three components are often reported as ubiquitous in the venom of different families of scorpions. Our results suggest that, at least calcins and scorpines, could be used as molecular markers in phylogenetic studies of scorpion venoms.


Subject(s)
Arthropod Proteins , Scorpion Venoms , Animals , Arthropod Proteins/genetics , Arthropod Proteins/metabolism , Exocrine Glands/metabolism , Gene Expression Profiling , Phylogeny , Proteomics , Scorpion Venoms/genetics , Scorpion Venoms/metabolism , Scorpions
2.
Neuroscience ; 209: 54-63, 2012 May 03.
Article in English | MEDLINE | ID: mdl-22406415

ABSTRACT

There is evidence to suggest that the neuroprotective effect of exposure of extremely low-frequency electromagnetic fields (ELF-EMF) may be due, at least in part, to the effect of these fields on neurotrophic factors levels and cell survival, leading to an improvement in behavior. This study was undertaken to investigate the neuroprotective effects of ELFEF in a rat model of 3-nitropropionic acid (3NP)-induced Huntington's disease. Behavior patterns were evaluated, and changes in neurotrophic factor, cell damage, and oxidative stress biomarker levels were monitored in Wistar rats. Rats were given 3NP over four consecutive days (20 mg/kg body weight), whereas ELFEF (60 Hz and 0.7 mT) was applied over 21 days, starting after the last injection of 3NP. Rats treated with 3NP exhibited significantly different behavior in the open field test (OFT) and the forced swim test (FST), and displayed significant differences in neurotrophic factor levels and oxidative stress biomarkers levels, together with a neuronal damage and diminished neuronal density, with respect neuronal controls. ELFEF improved neurological scores, enhanced neurotrophic factor levels, and reduced both oxidative damage and neuronal loss in 3NP-treated rats. ELFEF alleviates 3NP-induced brain injury and prevents loss of neurons in rat striatum, thus showing considerable potential as a therapeutic tool.


Subject(s)
Brain/radiation effects , Huntington Disease/therapy , Magnetic Field Therapy/methods , Nerve Growth Factors/radiation effects , Animals , Brain/metabolism , Disease Models, Animal , Electromagnetic Fields , Huntington Disease/metabolism , Male , Nerve Growth Factors/metabolism , Neurons/metabolism , Neurons/radiation effects , Rats , Rats, Wistar
3.
Med Chem ; 5(1): 44-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19149649

ABSTRACT

We investigated the effect of magnetic field stimulation (MS) on oxidative damage and skeletal muscle injury prompted by mepivacaine injection in the anterior tibial muscle of Wistar rats. The effects of mepivacaine and MS on oxidative stress were evaluated by lipid peroxidation, GSH levels and catalase activity. Muscle regeneration was analyzed by haematoxylin-eosin stained, NADH-TR histochemical reaction, desmin immunostaining as well as by morphometric parameters such as fibers density and fiber area were evaluated. Our data revealed that mepivacaine induced oxidative stress, that MS prevents the harmful effects induced by mepivacaine and that it facilitates the regeneration process of skeletal muscle. In conclusion, the results show the ability of MS to modify skeletal muscle response to mepivacaine.


Subject(s)
Magnetic Field Therapy , Mepivacaine/pharmacology , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiology , Oxidative Stress/drug effects , Oxidative Stress/physiology , Regeneration/drug effects , Animals , Free Radicals/metabolism , Injections, Intramuscular , Male , Mepivacaine/administration & dosage , Nitrites/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL